Philips, the #3 patent holder in the AI Biotech/Diagnostics sector, has signed a 10-year partnership with Rutherford Diagnostics. This strategic collaboration will not only bring Philips' radiology technology and Rutherford's healthcare expertise together, but also deliver advanced personalized diagnostic services to more people via the healthcare centers operated by Rutherford's parent company, Proton Partners International. Since Rutherford specializes in creating a network of diagnostic centers, this partnership can be expected to help Philips' diverse diagnostic technologies incorporating artificial intelligence to reach a wider audience.
